Search Within

Jason Konner

Formats
  1. Journal Article (83)
  2. Meeting Abstract (69)
  3. Correspondence (2)
  4. Book Section (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (156)
  2. GDMT, Medicine (156)
  3. Gynecologic Medicine Service (156)
  4. Gynecology Disease Management Team (156)
  5. Solid Tumor Oncology Division (156)
  6. Surgery (59)

More Groups

People
  1. Carol Aghajanian (85)
  2. William Tew (60)
  3. Paul Sabbatini (52)
  4. Martee Hensley (49)
  5. Alexia Iasonos (44)
  6. Roisin O'Cearbhaill (43)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (8)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Gynecologic Oncology (31)
  3. International Journal of Gynecological Cancer (14)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (9)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Elsevier Inc. (35)
  3. American Association for Cancer Research (15)
  4. Lippincott Williams & Wilkins (15)
  5. Oxford University Press (11)
  6. Springer (6)

More Publishers

Results (156)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FRa)-positive cancer
    Meeting Abstract

    Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; Harter, P.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
    Meeting Abstract

    Moore, K. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Banerjee, S.; Murphy, C.; Konner, J.; Lim, P.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Characterization of antitumor activity in the SORAYA study
    Meeting Abstract

    Matulonis, U. A.; Oaknin, A.; Pignata, S.; denys, H.; Colombo, N.; Van Gorp, T.; Konner, J. A.; Romeo, M.; Harter, P.; Murphy, C. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomized phase III study of maintenance selinexor versus placebo in endometrial cancer (ENGOT-EN5/GOG-3055/SIENDO): Impact of subgroup analysis and molecular classification
    Meeting Abstract

    Makker, V.; Perez-Fidalgo, J. A.; Bergamini, A.; Spitz, D. L.; Van Gorp, T.; Sehouli, J.; Klat, J.; Perri, T.; Oza, A. M.; Hogdall, E. V. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes
    Editorial

    Bolton, K. L.; Chen, D.; de la Fuente, R. C.; Fu, Z.; Murali, R.; Köbel, M.; Tazi, Y.; Cunningham, J. M.; Chan, I. C. C.; Wiley, B. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: A case series
    Journal Article

    Sia, T. Y.; Manning-Geist, B.; Gordhandas, S.; Murali, R.; Marra, A.; Liu, Y. L.; Friedman, C. F.; Hollmann, T. J.; Zivanovic, O.; Chi, D. S.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Effects of vigorous versus restorative yoga practice on objective cognition functions in sedentary breast and ovarian cancer survivors: A randomized controlled pilot trial
    Journal Article

    Deng, G.; Bao, T.; Ryan, E. L.; Benusis, L.; Hogan, P.; Li, Q. S.; Dries, A.; Konner, J.; Ahles, T. A.; Mao, J. J.
    Integrative Cancer Therapies (2022)

    Fulltext@MSK | Save